Cargando…
Case report: Primary hepatocellular carcinoma with portal vein tumor thrombus characterized by active tumor immune microenvironment achieving a complete response following treatment of combined immunotherapy
Portal vein tumor thrombus (PVTT) is a frequent complication in hepatocellular carcinoma (HCC). HCC patients with PVTT have the characteristics of less treatment tolerance and poor prognosis. Immunotherapy, especially combined immunotherapy, has been successfully used in advanced HCC. However, there...
Autores principales: | Zhong, Kaihang, Xu, Yuyan, Cheng, Yuan, Wen, Yaohong, Cai, Lei, He, Guolin, Huang, Huakun, Fu, Shunjun, Zhong, Xuefeng, Zheng, Yating, Chen, Tingting, Huang, Mengli, Pan, Mingxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471014/ https://www.ncbi.nlm.nih.gov/pubmed/36119069 http://dx.doi.org/10.3389/fimmu.2022.999763 |
Ejemplares similares
-
Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection
por: Xu, Yuyan, et al.
Publicado: (2023) -
Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges
por: Jiang, Jin-Fang, et al.
Publicado: (2017) -
Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy
por: Deng, Zhu-Jian, et al.
Publicado: (2022) -
Hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus
por: Kamiyama, Toshiya, et al.
Publicado: (2017) -
Portal vein tumor thrombus from gastric cancer
por: Liang Ong, Sidney Ching, et al.
Publicado: (2018)